Invention Grant
- Patent Title: Pharmaceutical use of 3, 4-bis-benzylsulfonylbutyronitrile
-
Application No.: US15262176Application Date: 2016-09-12
-
Publication No.: US09750714B2Publication Date: 2017-09-05
- Inventor: Joseph P. St. Laurent , Gerald S. Jones , David M. Bresse , Scott A. Goodrich
- Applicant: Olatec Therapeutics LLC
- Applicant Address: US NY New York
- Assignee: Olatec Therapeutics LLC
- Current Assignee: Olatec Therapeutics LLC
- Current Assignee Address: US NY New York
- Agency: Perkins Coie LLP
- Agent Viola T. Kung
- Main IPC: A61K31/277
- IPC: A61K31/277 ; C07C315/02 ; C07C317/28 ; C07C317/44 ; C07C319/12 ; A61K9/00

Abstract:
The present invention is directed to a method of treating inflammation or pain. The present invention is also directed to a method of treating an inflammatory skin disease or disorder, such as dermatitis, psoriasis, acne, or rosacea. The method comprises administering to the subject 3, 4-bis-benzylsulfonylbutyronitrile in an amount effective to reduce or eliminate the symptoms of the disease or disorder. Topical administration and oral administration are preferred route of administration.
Public/Granted literature
- US20170065550A1 PHARMACEUTICAL USE OF 3, 4-BIS-BENZYLSULFONYLBUTYRONITRILE Public/Granted day:2017-03-09
Information query